The incidence and mortality of lung cancer and their relationship to development in Asia by Pakzad, R. et al.
 
 
* Corresponding Author; 
 Address: Department of Clinical Epidemiology, Ilam University of Medical Sciences, Iran 
 E-mail: alidelpisheh@yahoo.com 
© 2014 by Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, All rights reserved. 
Iran J Pediatr; Vol 24 (No 6), Dec 2014 
Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir) 
 
Congenital Hypothyroidism Screening Program in Iran; a Systematic Review and 
Metaanalysis 
Yousef Veisani1, MSc; Kourosh Sayehmiri2, PhD; Shahab Rezaeian3, MSc; Ali Delpisheh*4, PhD 
1Student Research Committee, 2Prevention of Psychosocial Injuries Research Centre, Ilam University of 
Medical Sciences, Ilam, 3Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, 
4Department of Clinical Epidemiology, Ilam University of Medical Sciences, Ilam, Iran 
Received: Nov 28, 2013; Accepted: Sep 16, 2014; First Online Available: Oct 06, 2014 
Abstract 
Objective: Unrecognized congenital hypothyroidism (CH) leads to mental retardation. Newborn screening 
and thyroid therapy started within 2 weeks of age can normalize cognitive development. In this systematic 
review, the local results of the national CH screening program in different provinces in Iran are reviewed and 
evaluated. 
Methods: Literature on the CH screening, the national databases including SID, Medlib, Iran Medex, Magiran 
as well as international databases including PubMed/Medline, ISI Web of Knowledge and web of science, 
EMBASE, SCOPUS and Google Scholar.  Appraisal was guided by a checklist assessing clarity of aims and 
research questions. The 95% confidence intervals were calculated by I-square models. Meta regression was 
introduced to explore the heterogeneity between studies.  
Findings: We identified 25 samples including 1425124 neonates in our country. Data were Meta analyzed 
using random-effects models, and we found a TSH levels of 19633 babies in the first sampling were greater 
than the cut-off level (TSH ≥5mIU/L). The pooled recall rate was 0.014 (95 % CI: 0.013 – 0.015). According to 
Meta analysis the overall incidence of CH was 2/1000 (95% CI: .002 – .002). The incidence of CH did not 
appear to be increasing over time (P=0.08). 
Conclusion: Considering TSH ≥5mIU/L as a cut-off point for recalling neonates and low positive predictive 
value (14%) of this point shows that more investigation and research is needed for establishing accurate level 
of TSH as a criterion for recalling patients. 
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Introduction 
Congenital hypothyroidism (CH) is one of the most 
important causes of preventable mental 
retardation. The goal of neonatal CH screening 
programs is early diagnosis and treatment[1]. The 
delayed diagnosis made only on the basis of 
clinical findings may result in irreversible 
complications such as mental retardation and 
deafness[2,3]. The difficulty in recognizing CH and 
the serious consequences of delayed therapy have 
led to the introduction of screening programs for 
hypothyroidism in newborns by measuring 
thyroxine (T4) or thyroid-stimulating hormone 
(TSH or thyrotropin) in spots of blood collected 
via heel stick during the first few days of life[4]. 
     Screening programs for CH have been 
developed in Canada, the United States, parts of 
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Mexico, Western Europe, Japan, Australia and New 
Zealand, and they are under development in parts 
of many countries in Eastern Europe, Asia, South 
America and Africa. Of the worldwide birth 
population of 127 million, it is estimated that 25 
percent undergo screening for CH[5]. In Iran the 
screening program was first carried out in 1987 
by Azizi et al[6] and was included to the health care 
service in 2005. Early diagnosis, made possible by 
neonatal screening, has increased the need for 
etiologic classification at a very young age, both 
for the treatment of the affected neonates and 
genetic counseling of the family[7]. 
     In Iran, preliminary studies on national CH 
screening program have emerged [11-35]. Within the 
above-mentioned background we reviewed the 
local results of the national CH screening program 
in different provinces of the country in terms of 
TSH cut-off level. Frequency of cases that required 
recall and treatment along with stages of the 
disease before treatment in boys and girls are 
evaluated. 
Subjects and Methods  
We identified publications estimating and 
reporting of results for national CH screening 
program among Iranian neonates in September 
2013 that were published between  January 1, 
1995 and  August 31, 2013. The review is 
conducted in accordance with PRISMA 
guidelines[8]. Literature on the CH screening 
program among Iranian neonates was acquired 
through searching the national databases 
including:  Scientific Information Databases (SID), 
Global Medical Article Limberly (Medlib), Iranian 
Biomedical Journal (Iran Medex), Iranian Journal 
Database (Magiran) as well as international 
databases including PubMed/Medline, ISI Web of 
Knowledge and web of science, EMBASE, SCOPUS 
and Google Scholar. The search strategy was 
limited to the Persian and/or English language 
and articles published up until  August 31,  2013 
were considered. All publications with medical 
subject headings (MeSh) and keywords in title, 
abstract and text for words including congenital 
hypothyroidism and Iran were investigated. 
Iranian scientific databases were searched only 
using the keyword ‘Congenital hypothyroidism’, as 
these databases do not distinguish synonyms from 
each other and do not allow sensitive search 
operation using linking terms such as ‘AND’, ‘OR’ 
or ‘NOT’. Consequently, this single keyword search 
was the most practical option. The Congenital 
hypothyroidism, Hypothyroidism, Congenital and 
Iran MeSh combined with the operator "OR" vs 
"AND". 
     All identified papers were critically appraised 
independently by two reviewers. Disagreements 
between reviewers were resolved by consensus. 
Appraisal was guided by a checklist assessing 
clarity of aims and research questions. inclusion 
criteria were all related articles published from 
the local results of the national CH screening 
program in Iran (notates between the 3rd and 5th 
day of life on filter paper, by puncturing the heel) 
using valid databases. Studies upon neonates 
overlapping time intervals of sample collection 
from the same origin (for example articles 
published in both Persian and English language), 
inappropriate study design and inadequate 
reporting of results were important exclusion 
criteria. 
     The data were extracted on the year of study, 
geographical location, gender, author, title, setting 
of the study, sample size, recall rate and incidence 
of CH using a standardized and pre-piloted data 
extraction form. Data extraction was undertaken 
by the first reviewer and checked by a second 
reviewer, also the process was discussed and 
piloted by both reviewers. All identified papers 
were critically appraised independently by both 
reviewers. Disagreements were resolved through 
discussion. Appraisal was guided by a checklist 
assessing clarity of aims and research questions. 
These data-abstraction forms were reviewed and 
eligible papers were entered into the meta-
analysis.  
     I-squared model was used for combining results 
of studies in meta-analysis[9]. Significance level 
was <0.1 and I-squared statistic for estimates of 
inconsistency within the meta-analyses[10]. 
     Univariate and multivariate Meta regression 
analyses were used to explore possible sources of 
heterogeneity among studies. We analyzed 
sources of heterogeneity by subgroup and meta 
regression analysis using dichotomous and 
continuous variables. Meta-regression was used to 
show trend of variation of prevalence during time. 
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Egger’s test was conducted to examine potential 
publication bias. Egger’s test can reveal a 
symmetric or asymmetric funnel plot. The latter 
indicates the existence of a significant publication 
bias or a systematic heterogeneity between 
studies. Data manipulation and statistical analyses 
were done using STATA software, version 11.2. P 
values <0.05 were considered as statistically 
significant. 
Findings 
The final data-set consisted of 68 publications, 33 
studies were excluded as they did not meet the 
inclusion criteria. There were 7 studies in English 
and 18 studies in Persian of the finally adopted 25 
studies and were published between 1995 and 
2013. The studies were conducted in 18 different 
provinces; these publications provided data on 
1.425.124 neonates (Table 1 and Fig 1). TSH levels 
of 19.633 babies in the first sampling were greater 
than the cut-off level (TSH ≥5mIU/L). The pooled 
recall rate was 0.014 (95% CI: 0.013– 0.015) (TSH 
levels of patients whose first heel TSH level was 
>5 mIU/L are given in Table 1). According to Meta 
analysis the overall incidence of CH was 2/1000 
live births (95% CI:  .002 –.002) (Fig 2). According 
to subgroup analysis based on provinces the 
highest incidence occurring in the Markazi 
province was 0.003 (95%CI: 0.002-0.004) and 
lowest incidence occurring in Tehran, Gilan, Fars, 
Kerman, Mazandaran and Zanjan provinces was 
0.001 (95%CI: 0.001-0.001) (Table 2). 
     There were 0.46 (95% CI: 0.45–0.46) female 
and 0.54 (95% CI: 0.54–0.54) male infants who 
had CH. In this study there was no statistically 
significant difference between males and females 
(P=0.5). The heterogeneity between studies was 
98.7% with an I-square (I2) statistics (541.33, 
DF=7, P<0.001). 
     Fig. 3 shows that the CH incidence has had no 
increasing trend during 1995 till 2013. Meta- 
regression analysis found that sample size does
Table 1: Characteristics of included reports 
Study location 
(Province) 
        Authors 
 
Year of 
study 
No. of 
patients 
Recall 
rate 
Incidence 
Khuzestan Aminzadeh et al[11]  2010 35655 0.0352 0.0020 
Tehran Ordoukhani et al[12]  2002 35067 0.0106 0.0010 
Khorasan Namakin et al[13]  2012 38987 0.0321 0.0183 
Gilan Kalantari et al[14]  2004 3000 0.0200 0.0010 
Markazi Dorreh et al[15]  2010 25658 0.0236 0.0030 
Fars Karamizadeh et al[16]  2012 63031 0.0200 0.0010 
Isfahan Hashemipour et al[17]  2007 113282 0.0320 0.0030 
Kerman Eftekhari et al[18]  2008 3000 0.0070 0.0010 
Kurdistan Nele et al[19]  2011 50539 0.0200 0.0020 
Mazandaran Akhi et al[20]  2011 45218 0.0460 0.0016 
Ghazvin Saffari et al[21]  2009 33488 0.0320 0.0020 
Gilan Mohtasham et al[22]  2007 9284 0.0315 0.0017 
Yazd Nouri Shadkam et al[23]  2008 13022 0.0620 0.0030 
East Azerbaijan Zeinalzadeh et al[24]  2011 62459 0.0250 0.0017 
Kermanshah Khassi et al[25]  2011 30265 0.0018 0.0017 
West Azerbaijan Eshratkhah et al[26]  2011 19141 0.0200 0.0020 
Tehran Mostafavi et al[27]  1995 1014 0.0800 0.0060 
Tehran Ordookhani et al[28]  2003 20107 0.0013 0.0010 
Zanjan Valizadeh et al[29]  2011 18008 0.0410 0.0010 
Isfahan Honarpisheh et al[30]  2002 500 0.0500 0.0100 
Isfahan Hashemipour et al[31]  2010 225224 0.0170 0.0020 
Isfahan Hashemipour et al[32]  2007 93381 0.0111 0.0030 
Mazandaran Haghshenas et al[33]  2012 10573 0.0200 0.0005 
Isfahan Ghasemi et al[34]  2013 464648 0.0210 0.0013 
Mazandaran Nasehi et al[35]  2010 10573 0.0140 0.0140 
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Fig. 1: Flow diagram showing the different steps involved in searching for relevant publications (1995–2013). 
not significantly affect heterogeneity for the factor 
‘CH incidence’ (Reg Coef = 0.028, P=0.4). Meta-
regression showed an association between the 
year of study and prevalence rate of CH incidence 
and demonstrated causes of the variability in the 
results of studies. Meta-regression showed that 
variability in CH incidence is not a significant 
effect for years (Reg Coef=0.031, P=0.08). There 
was no evidence of publication bias (Egger’s test 
β0: 0.26; P=0.6) (Fig. 4) so we tried to consider
NOTE: Weights are from random effects analysis
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Fig. 2: Forest plots of recall rate (A) and incidence of CH (B) for I-squared model meta-analyses (Weights are from              
I-squared model). The diamond represents the overall result 
Not relevant (n =10) 
Not relevant (n =2) 
 
Searching in inner databases Medlib, MAG Iran, IranMedex, 
SID and external databases MEDLINE, Web of Science, 
PubMed, EMBASE, SCOPUS, Google Scholar (n=68) 
Title screened for inclusion criteria, and screened for 
retrieval (n=57) 
Abstracts screened, relevant studies identified and 
retrieved (n=37) 
Full-text articles, relevant studies identified and retrieved 
(n=27) 
25 publications included in final meta-analysis 
Duplicated studies (n=11) 
Not relevant (n = 15) and 
Indistinguishable (n = 5) 
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Table 2: Subgroup analysis of CH Incidence based on various provinces in Iran 
Province 
No. of 
studies 
No. of 
Subjects 
CH Incidence  
(95% CI) 
heterogeneity model 
I-squared P value 
Khuzestan 1 35655 0.002(0.002-0.002) 0.00 0 I-squared 
Tehran 3 56188 0.001(0.001-0.001) 4.24 0.12 I-squared 
Khorasan 1 38987 0.018(0.017-0.020) 0.00 0 I-squared 
Gilan 2 12284 0.001(0.001-0.002) 0.95 0.33 I-squared 
Markazi 1 25658 0.003(0.002-0.004) 0.00 0 I-squared 
Fars 1 63031 0.001(0.001-0.001) 0.00 0 I-squared 
Isfshan 5 464648 0.002(0.002-0.002) 186.99 0.000 I-squared 
Kerman 1 3000 0.001(0.001-0.002) 0.00 0 I-squared 
Kurdisatan 1 50539 0.002(0.002-0.002) 0.00 0 I-squared 
Mazandaran 3 66364 0.001(0.001-0.001) 15.13 0.001 I-squared 
Ghazvin 1 33488 0.002(0.002-0.002) 0.00 0 I-squared 
Yazd 1 13022 0.002(0.003-0.004) 0.00 0 I-squared 
East Azerbaijan 1 62459 0.002(0.001-0.002) 0.00 0 I-squared 
Kermanshah 1 30265 0.002(0.001-0.002) 0.00 0 I-squared 
West Azerbaijan 1 19141 0.002(0.001-0.003) 0.00 0 I-squared 
Zanjan 1 18008 0.001(0.001-0.001) 0.00 0 I-squared 
Pooled of CH 25 1425124 0.002(0.002-0.002) 911.79 0.000 I-squared 
 
most of published articles in this subject. 
Discussion 
We report a systematic review of the CH screening 
program in neonates based on 25 separate 
samples (from 68 publications) based on 
1.425.124 neonates. In addition, we have, to our 
knowledge for the first time, reviewed reports in 
CH screening program in Iran and employed meta-
regression analysis to explore sources of 
heterogeneity between studies. 
     The CH screening program has been 
implemented in Iran since 2006. It is based on TSH 
measurement by heel prick between the 3rd and 
5th day of life. The most important goals of CH 
screening programs are early diagnosis and 
treatment of CH. Preferably, the diagnosis must be 
confirmed within the first 14 days, and treatment 
must be started. There are also some studies 
emphasizing the necessity of starting the 
treatment no later than three months (ideally 1 
month) after the first sample[36]. 
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Fig. 3: Meta-regression plots of change in CH incidence according to changes in continuous study moderator’s year 
and sample size 
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Begg's funnel plot with pseudo 95% confidence limits
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Fig. 4: Begg's funnel plot (pseudo 95% confidence limits) showing means difference 
in prevalence of hypothyroidism (CH) by standard error of mean difference 
     The pooled recall rate was (0.014 per case) 
according to cutoff point for recalling the patients 
in screening program and the overall incidence of 
CH was (2/1000 live births). It was reported that 
the prevalence of CH in the Greek Cypriot 
population 1990-2000 was 1/1800[37]. The results 
of the screening program for CH in Italy noted the 
incidence of CH as 1/1446 between 1999 and 
2005[38]. Nonetheless, CH is more common in 
Eastern countries, for example, the incidence of 
permanent CH was found as 1/748 in Iran 2002-
2005[7]. CH incidence before the CH screening 
program in Turkey was reported as 1/2736-
1/2326[39]. A study from Konya noted that the CH 
incidence 1999-2007 was 1/2183[40]. At the 
present time, there is a good policy and 
appropriate methods are available for screening of 
CH in Iran, but it seems that the cut-off point for 
TSH ≥5mIU/L in whole blood overestimates the 
real number of patients. 
     According to these findings whole blood 
TSH≥15mIU/L seems to be a more reliable and 
cost effective cutoff point for recalling patients in 
screening programs of CH. In Bosnia and 
Herzegovina, the TSH cutoff value for recall was 
≥20mIU/L in whole blood[41], ≥15mIU/L in 
Mexico[42] and ≥25mIU/L in Thailand[43]. 
     The strengths of this review include the large 
number of samples and neonates included, and 
therefore the ability to examine recall and 
incidence rates. In conclusion, lowering the cut-off 
level will probably increase the cost of the 
screening program; however, the number of the 
missed cases due to high cut-off levels is 
substantial. Considering TSH ≥5mIU/L as a cut-off 
point for recalling neonates and low positive 
predictive value (14%) of this point shows that 
more investigation and research is needed for 
establishing accurate level of TSH as a criterion for 
recalling patients. 
Conclusion 
Considering TSH ≥5mIU/L as a cut off point for 
recalling neonates and low positive predictive 
value (14%) of this point shows that more 
investigation and research is needed for 
establishing accurate level of TSH as a criterion for 
recalling patients. 
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